A tight-junction protein normally found only in the embryo that reappears in ovarian, testicular, endometrial and lung cancers, making it a clean target for ADCs and CAR-T. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.
Four-transmembrane tight-junction claudin expressed in embryonic epithelia and germ cells; silenced after development, re-expressed in cancers via epigenetic derepression.
| Cancer | Prevalence | Measure | Note | Source |
|---|---|---|---|---|
| Testicular germ cell tumours | 90% | IHC positivity | ||
| Ovarian cancer | 50-60% | IHC positivity | varies by antibody and cutoff |
Approximate, population-level figures; the measure column says what was counted. Ranges show the midpoint as a bar.
No product in the corpus is aimed at this target yet.
No trial in the corpus names this target or one of its products.
No recorded escape route names this target.
No pathway diagram carries this target as a node.
No companion diagnostic in the registry measures this target.
No model entry for this target yet; check the cancer entries on the models page.
No open questions recorded for this target yet. Suggest one.
Query for this target: (TITLE:"Claudin 6" OR ABSTRACT:"Claudin 6" OR TITLE:"CLDN6" OR ABSTRACT:"CLDN6") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Claudin 6, not a curated reading list.
The dossier as machine-readable JSON, at /api/v1/dossiers/cldn6.json: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/cldn6.json. Licence CC BY-NC 4.0.